C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2011
03/10/2011	US20110059491 Beta-amylase, gene coding therefor and manufacturing method thereof
03/10/2011	US20110059488 Anti-MPL Antibodies
03/10/2011	US20110059486 Non-splicing variants of gp350/220
03/10/2011	US20110059485 Plasmids from Thermophilic Organisms, Vectors Derived Therefrom, and Uses Thereof
03/10/2011	US20110059484 Process for producing polypeptides
03/10/2011	US20110059473 Proteins with pteridine glycosyltransferase activity and analysis method using the same
03/10/2011	US20110059461 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase
03/10/2011	US20110059456 System for the Cell-Specific and Development-Specific Selection of Differentiating Embryonic Stem Cells, Adult Stem Cells and Embryonic Germline Cells
03/10/2011	US20110059443 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift
03/10/2011	US20110059439 Composition and method for imaging stem cells
03/10/2011	US20110059436 Methods for sequence determination
03/10/2011	US20110059225 Rice and products thereof having starch with an increased proportion of amylose
03/10/2011	US20110059173 encoding a polypeptide comprising a carboxy-terminal amino acid sequence of an alpha Connexin; reduces scar formation
03/10/2011	US20110059160 Methods and compositions for targeted gene modification
03/10/2011	US20110059135 Capsid-Incorporated Antigen for Novel Adenovirus Vaccine
03/10/2011	US20110059130 Prophylactic and therapeutic influenza vaccines, antigens, compositions and methods
03/10/2011	US20110059129 Avian influenza virus vaccine and a method for preparing
03/10/2011	US20110059120 Glucan-based vaccines
03/10/2011	US20110059110 Antibody (11c7) anti nogo-a and its pharmaceutical use
03/10/2011	US20110059098 Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof
03/10/2011	US20110059094 Antitumor effects of insulin-responsive dna binding protein-1 (irdbp-1)
03/10/2011	US20110059090 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors
03/10/2011	US20110059077 Humanized anti-human alpha 9-integrin antibody
03/10/2011	US20110059075 Aglycosylated immunoglobulin mutants
03/10/2011	US20110059073 Method for treating infectious disease using monoclonal antibodies
03/10/2011	US20110059072 Method for treating cancer using monoclonal antibodies
03/10/2011	US20110059067 Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
03/10/2011	US20110059066 PAKs as Modifiers of the CHK Pathway and Methods of Use
03/10/2011	US20110059063 Antigen binding proteins that bind PAR-2
03/10/2011	US20110059058 Strain of Lactobacillus Rhamnosus
03/10/2011	US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins
03/10/2011	US20110059055 Treating myelin diseases with optimized cell preparations
03/10/2011	US20110059053 Method of treating biocells
03/10/2011	US20110059045 Pharmaceutical composition for cancer treatment
03/10/2011	US20110059042 Substituted il-15
03/10/2011	US20110059021 Process for preparing variant of erysipelothrix rhusiopathiae surface protective antigen in e. coli
03/10/2011	US20110059015 Vaccine
03/10/2011	CA2773291A1 Cells and methods for obtaining them
03/10/2011	CA2773083A1 Immunity-inducing agent
03/10/2011	CA2773061A1 Method for specifically producing a joined dna fragment comprising a sequence derived from a target gene
03/10/2011	CA2773002A1 Enhancer for promoter, and use thereof
03/10/2011	CA2772931A1 Compositions and methods for treatment of neuropathic pain
03/10/2011	CA2772921A1 Type 1 interferon diagnostic
03/10/2011	CA2772859A1 Variant cbh2 cellulases and related polynucleotides
03/10/2011	CA2772715A1 Mutant smoothened and methods of using the same
03/10/2011	CA2772628A1 Dual variable domain immunoglobulins and uses thereof
03/10/2011	CA2772619A1 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
03/10/2011	CA2772613A1 Anti-gitr antibodies
03/10/2011	CA2772469A1 Protein glycosylation
03/10/2011	CA2772076A1 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
03/10/2011	CA2771965A1 Treatment of vasculoproliferative conditions
03/10/2011	CA2770588A1 Td probe and its uses
03/09/2011	EP2293067A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
03/09/2011	EP2292801A2 Compositions and methods for detecting hepatitis B virus
03/09/2011	EP2292798A1 Rna in situ hybridization
03/09/2011	EP2292791A1 Nuclear export reporter system
03/09/2011	EP2292790A1 Nuclear export reporter system
03/09/2011	EP2292789A1 Modified surfaces as solid supports for nucleic acid purification
03/09/2011	EP2292787A1 Pyrophosphorolysis activated polymerization (PAP)
03/09/2011	EP2292786A2 Diagnosing and monitoring cardiac transplant rejection based on marker expression levels
03/09/2011	EP2292784A2 Enzymes having alpha amylase activity and methods of use thereof
03/09/2011	EP2292781A1 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
03/09/2011	EP2292780A2 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
03/09/2011	EP2292779A2 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
03/09/2011	EP2292778A1 Use of lentiviral triplex forming sequences for nuclear transfer of nucleotide sequences
03/09/2011	EP2292777A1 Transgenic sweet sorghum with altered lignin composition and process of preparation thereof
03/09/2011	EP2292776A1 Manipulation of genes of the mevalonate and isoprenoid pathways to create novel traits in transgenic organisms
03/09/2011	EP2292775A2 A method for producing plants which are resistant to closteroviruses
03/09/2011	EP2292774A1 Disease resistant tomato plants
03/09/2011	EP2292773A1 Genes and uses for plant improvement
03/09/2011	EP2292772A1 HIV vaccination with a DNA encoding a HIV polypeptide and a HIV polypeptide
03/09/2011	EP2292771A2 Sense mRNA therapy
03/09/2011	EP2292770A2 Methods and means for producing proteins with predetermined post-translational modifications
03/09/2011	EP2292769A1 Fermentation process
03/09/2011	EP2292768A1 Use of AHAS mutant genes as selection marker in potato transformation
03/09/2011	EP2292767A2 Polypepdides having DNA polymerase activity
03/09/2011	EP2292766A2 Polypeptides having DNA polymerase activity
03/09/2011	EP2292765A1 Flavonoid 3',5' Hydroxylase gene sequences and uses therefor
03/09/2011	EP2292764A1 Flavonoid 3',5' hydroxylase gene sequences and uses therefor
03/09/2011	EP2292763A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
03/09/2011	EP2292762A2 VMP-like sequences of pathogenic Borrelia species and strains
03/09/2011	EP2292761A1 Vascular adhesion molecules and modulation of their function
03/09/2011	EP2292760A2 Mammalian cytokines, receptors, related reagents and methods
03/09/2011	EP2292759A1 Methods for transforming plants to express bacillus thuringiensis delta-endotoxins
03/09/2011	EP2292758A2 Uses of mammalian cytokine; related reagents
03/09/2011	EP2292757A2 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs
03/09/2011	EP2292756A1 Methods and compositions involving miRNA and miRNA inhibitor molecules
03/09/2011	EP2292755A1 Methods and compositions involving miRNA and miRNA inhibitor molecules
03/09/2011	EP2292754A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
03/09/2011	EP2292753A1 Method for diagnosing non-small cell lung cancers by tRNA-dihydrouridine synthase activity of URLC8
03/09/2011	EP2292750A2 Alanine 2, 3 aminomutases
03/09/2011	EP2292749A2 Alanine 2, 3 aminomutases
03/09/2011	EP2292745A1 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
03/09/2011	EP2292744A1 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
03/09/2011	EP2292739A1 Method for preparing differentiated avian cells and genes involved in the maintenance of pluripotency
03/09/2011	EP2292738A1 Double-transfected cell line useful for the identification of transport inhibitors
03/09/2011	EP2292666A2 Neoplasm specific antibodies and uses thereof
03/09/2011	EP2292664A2 Multispecific deimmunized CD3-binders
03/09/2011	EP2292663A2 Antagonistic human light-specific human monoclonal antibodies
03/09/2011	EP2292662A2 Assay and reagents for quantifying hBNP

1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 4023